V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300005899 | 300004038 | 1.53 | 52.6 | Neo-adjuvant (N) | 2018-08-09 | 2018-08-09 | CISPLATIN + RT | N | N | 300008300 | CISPLATIN + RT |
| 300005900 | 300004039 | null | 95.6 | Adjuvant (A) | 2016-09-29 | 2016-10-21 | Cisplatin 100 + RT(H&N) 1 day | N | N | 300008305 | CISPLATIN + RT |
| 300005901 | 300004039 | 1.6 | 65.7 | Palliative (P) | 2017-02-23 | 2017-03-07 | GEMCITABINE | 02 | N | 300008305 | GEMCITABINE |
| 300005902 | 300004040 | null | 80 | null | 2018-01-01 | 2018-01-01 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | null | 300008308 | GEMCITABINE |
| 300005903 | 300004040 | 1.72 | 69 | null | 2017-07-23 | 2017-08-31 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 300008308 | GEMCITABINE |
| 300005904 | 300004040 | 1.71 | 80.9 | Curative (C) | 2016-11-30 | 2016-12-06 | Cisplatin 100 + RT(H&N) 1 day | 02 | null | 300008308 | CISPLATIN + RT |
| 300005905 | 300008077 | 1.59 | 60 | Curative (C) | 2015-10-15 | 2015-11-05 | Cisplatin + Radiotherapy | N | N | 300008318 | CISPLATIN + RT |
| 300005906 | 300004041 | 1.84 | 75.2 | Curative (C) | 2017-12-04 | 2017-12-04 | CISPLATIN + RT | N | N | 300008326 | CISPLATIN + RT |
| 300005907 | 300004041 | 1.63 | 75.2 | Curative (C) | 2014-12-07 | 2014-11-30 | Cisplatin + Radiotherapy | 02 | N | 300008326 | CISPLATIN + RT |
| 300005908 | 300004041 | 1.79 | 75 | Palliative (P) | 2014-07-04 | 2014-07-24 | Gemcitabine 1000mg/m2 D1 8 15 | null | null | 300008326 | GEMCITABINE |
| 300005909 | 300004042 | 1.54 | 76.8 | Curative (C) | 2017-11-07 | 2017-11-15 | Cisplatin + Radiotherapy | 02 | N | 300008338 | CISPLATIN + RT |
| 300005910 | 300004043 | 1.59 | 109.95 | Curative (C) | 2016-04-28 | 2016-05-03 | Cisplatin + Radiotherapy | 2 | N | 300008338 | CISPLATIN + RT |
| 300005911 | 300008078 | 1.86 | 79.5 | Curative (C) | 2015-04-24 | 2015-05-21 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 300008350 | CISPLATIN + RT |
| 300005912 | 300004044 | 1.7 | 71.3 | Adjuvant (A) | 2013-06-21 | 2016-03-18 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 300008356 | GEMCITABINE |
| 300005913 | 300004044 | 1.82 | 83 | Curative (C) | 2016-07-31 | 2016-08-11 | Cisplatin + Radiotherapy | 02 | N | 300008356 | CISPLATIN + RT |
| 300005914 | 300004045 | 1.67 | 82.5 | Curative (C) | 2014-01-15 | 2014-01-15 | Cisplatin 100 + RT(H&N) 1 day | N | N | 300008384 | CISPLATIN + RT |
| 300005915 | 300004045 | 1.79 | 69 | null | 2017-07-01 | 2017-07-10 | Gemcitabine weekly | N | N | 300008384 | GEMCITABINE |
| 300005916 | 300004046 | 1.52 | 71.4 | Palliative (P) | 2016-01-29 | 2016-02-08 | CISPLATIN + GEMCITABINE | null | null | 300008401 | CISPLATIN + GEMCITABINE |
| 300005917 | 300004047 | 1.83 | 78 | Curative (C) | 2017-04-10 | 2017-04-23 | CISPLATIN + RT | 02 | N | 300008405 | CISPLATIN + RT |
| 300005918 | 300004048 | 1.6 | 102 | Curative (C) | 2017-12-29 | 2017-12-31 | CompARE Trial | 02 | N | 300008410 | CISPLATIN + FLUOROURACIL |
| 300005919 | 300004051 | 1.69 | null | Curative (C) | 2014-03-13 | 2014-05-13 | Cisplatin | N | Y | 300008423 | CISPLATIN |
| 300005920 | 300004052 | null | 98 | Curative (C) | 2015-12-11 | 2015-12-16 | Cetuximab + Radiotherapy Maint | 2 | Y | 300008426 | CETUXIMAB + RT |
| 300005921 | 300004052 | 1.9 | 91 | Curative (C) | 2017-08-07 | 2017-08-13 | CARBOPLATIN | 02 | Y | 300008426 | CISPLATIN + FLUOROURACIL |
| 300005922 | 300004053 | 1.6 | 48.4 | Curative (C) | 2015-08-09 | 2015-09-21 | Cytarabine intrathecal | N | N | 300008443 | CETUXIMAB + RT |
| 300005923 | 300004053 | 1.67 | 54.8 | Curative (C) | 2015-01-07 | 2015-02-20 | Cisplatin 7 day | 02 | Y | 300008443 | CETUXIMAB + RT |
| 300005924 | 300004054 | 1.83 | 64.1 | Palliative (P) | 2017-03-23 | 2017-08-24 | Cisplatin +Fluorouracil (3 wk) | 2 | Y | 300008456 | CETUXIMAB + RT |
| 300005925 | 300004054 | 1.77 | 89.2 | Not known (9) | 2013-08-07 | 2013-09-11 | FLUOROURACIL + RT | N | Y | 300008456 | CISPLATIN + FLUOROURACIL + RT |
| 300005926 | 300004055 | 1.6 | 65.5 | Not known (9) | 2016-03-05 | 2016-04-04 | Cisplatin 7 day | N | null | 300008464 | DE-ESCALATE TRIAL |
| 300005927 | 300004055 | 1.55 | 65.2 | Palliative (P) | null | 2014-12-30 | Cisplatin | N | N | 300008464 | CETUXIMAB |
| 300005928 | 300004056 | null | null | Adjuvant (A) | 2016-07-22 | 2016-08-12 | Carboplatin + Paclitaxel (3 weekly) | null | null | 300008474 | CAPECITABINE |
| 300005929 | 300004057 | 1.64 | 47 | Adjuvant (A) | 2017-05-27 | 2017-09-26 | FLUOROURACIL | N | Y | 300008487 | CISPLATIN + FLUOROURACIL + RT |
| 300005930 | 300006652 | 1.66 | 75.4 | Adjuvant (A) | null | 2018-04-17 | Carboplatin + Cetux + FU (>Cycle 2) | null | Y | 300008489 | CETUXIMAB |
| 300005931 | 300004058 | 1.56 | 61 | Palliative (P) | 2017-05-20 | 2017-06-17 | CETUXIMAB + RT | N | N | 300008491 | BEVACIZUMAB |
| 300005932 | 300004059 | 1.49 | null | Palliative (P) | 2018-07-02 | 2018-11-22 | CARBOPLATIN | N | Y | 300008494 | CETUXIMAB + RT |
| 300005933 | 300004060 | 1.59 | null | null | 2017-11-02 | 2017-11-04 | ESPAC-4 TRIAL | N | null | 300008495 | CETUXIMAB |
| 300005934 | 300004060 | null | 60 | Curative (C) | 2016-12-04 | 2016-12-16 | Carboplatin AUC 6 - 10 | N | Y | 300008495 | CETUXIMAB |
| 300005935 | 300004060 | 1.57 | 65 | Curative (C) | 2016-12-30 | 2017-01-31 | DE-ESCALATE TRIAL | 02 | null | 300008495 | CETUXIMAB + RT |
| 300005936 | 300004060 | 1.08 | 45 | Disease modification (D) | 2015-11-22 | 2015-12-02 | LUX TRIAL | 02 | N | 300008495 | CISPLATIN |
| 300005937 | 300004061 | 1.74 | 72.5 | Adjuvant (A) | 2016-02-16 | 2016-02-16 | CARBOPLATIN + RT | N | Y | 300008533 | CETUXIMAB + RT |
| 300005938 | 300004061 | 1.58 | 64.3 | Curative (C) | 2015-12-26 | 2016-02-20 | Cetuximab 7 day (>Cycle 2) | 02 | Y | 300008533 | CISPLATIN + FLUOROURACIL + RT |
| 300005939 | 300004062 | null | 67.7 | Curative (C) | 2014-04-24 | 2014-05-17 | Cisplatin +Fluorouracil (3 wk) | N | N | 300008538 | CAPECITABINE + OXALIPLATIN |
| 300005940 | 300004063 | null | 79.3 | null | 2014-05-03 | 2014-05-03 | CETUXIMAB + RT | N | null | 300008549 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300005941 | 300004064 | 1.81 | null | Curative (C) | 2016-07-25 | 2016-08-18 | Folfirinox | 02 | null | 300008554 | OXALIPLATIN |
| 300005942 | 300004066 | 1.78 | null | Curative (C) | 2014-09-11 | 2014-10-23 | NIVOLUMAB | 2 | N | 300008554 | BEVACIZUMAB |
| 300005943 | 300006658 | 1.7 | 88.3 | Palliative (P) | 2015-10-13 | 2015-10-19 | Capecitabine + Oxaliplatin 21day | N | N | 300008585 | CARBOPLATIN |
| 300005944 | 300004069 | 1.59 | 57.4 | Curative (C) | null | 2015-02-20 | Cisplatin + Docetaxel +Fluorouracil | null | null | 300008587 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300005945 | 300004070 | 1.58 | null | Curative (C) | 2015-07-29 | 2015-08-04 | CAPECITABINE + RT | N | Y | 300008596 | CARBOPLATIN |
| 300005946 | 300004071 | 1.75 | 74.4 | Curative (C) | 2017-01-13 | 2017-01-18 | CAPECITABINE + RT | N | Y | 300008597 | CISPLATIN |
| 300005947 | 300004071 | 1.49 | 0 | Curative (C) | 2015-05-28 | 2015-05-28 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300008597 | TRIAL |
| 300005948 | 300007683 | 1.56 | 58.8 | Curative (C) | 2016-02-02 | 2016-03-05 | null | 02 | N | 300008606 | CARBOPLATIN |